Research by University of Illinois Cancer Center members, trainees and co-authors was featured as part of the American Society of Clinical Oncology (ASCO) 2023 Annual Meeting in June in Chicago. Details below:
Relevance and accuracy of ChatGPT-generated NGS reports with treatment recommendations for oncogene-driven NSCLC
Zac Hamilton, Noor Naffakh, Natalie Reizine, Frank Weinberg, Shikha Jain, Vijayakrishna Gadi, Christopher Bun, Ryan Nguyen
The intersection of neighborhood-level disadvantage and overall lung cancer survival
Kathleen Kennedy, Ignacio Jusue-Torres, Ian Buller, Emily Rossi, Apurva Mallisetty, Kristen Rodgers, Ryan Nguyen, Frank Weinberg, Israel Rubinstein, James Herman, Lawrence Feldman, Malcolm Brock, Melinda Aldrich, Alicia Hulbert
The FOR ME (Fostering Opportunities in Research through Messaging and Education) study: Developing a culturally sensitive narrative intervention to promote equity in clinical trials
Neha Hippalgaonkar, Ryan Nguyen, Leslie Carnahan, Vida Henderson, Eliza Cohn, Tigist Mersha, Kauthar Salum, Ana Williams, Paramjeet Khosla, Anne Marie Murphy, Lolita Coleman, Beluah Brent, Kent Hoskins
Chronic opioid use and effects on survival in patients with advanced stage malignancies treated with immunotherapy
Michael Weinfeld, Li Liu, Mary Pasquinelli, Ryan Nguyen, Lawrence Feldman, Frank Weinberg
Ryan Nguyen, Leslie Carnahan, Eliza Cohn, Kauthar Salum, Neha Hippalgaonkar, Tigist Mersha, Ana Williams, Robbin Block, Kent Hoskins, Vida Henderson
The FOR US (Fostering Opportunities in Research Using Marketing Strategies) study
Ryan Nguyen, Leslie Carnahan, Eliza Cohn, Kauthar Salum, Neha Hippalgaonkar, Tigist Mersha, Ana Williams, Robbin Block, Kent Hoskins, Vida Henderson
Clinical outcomes in patients with metastatic non-small cell lung cancer and head and neck squamous cell cancer treated with immune checkpoint inhibitors according to COVID-19 vaccination status
Karam Khaddour, Josette Kamel, Natalie Meeder, Xu Ziqiao, Cuellar Sandra, Mary Pasquinelli, Ryan Nguyen, Li Liu, Vijayakrishna Gadi, Lawrence Feldman, Frank Weinberg
Impact of race on BluePrint genomic subtyping in HER2+ breast cancer
Sonya Reid, Tuya Pal, Xiao-Ou Shu, Lindsay Venton, Jennifer Whisenant, Kent Hoskins, Eduardo Dias, Rakhshanda Layeequr Rahman, Jennifer Wei, Sahra Uygun, Ciera Singleton, Andrea Menicucci, Patricia Dauer, William Audeh
Updated results of the phase 1 I-FLOAT trial: Safety and efficacy of combining genotype-guided irinotecan with 5FU, leucovorin, oxaliplatin and docetaxel (gFOLFOXIRITAX) in advanced upper GI cancers
Koosha Paydary, Colton Loew, Aurelie Desgardin, Ardaman Shergill, Natalie Reizine, Chanelle Robinzine, Christine Racette, Elena Ignatiev, Anu Neerukonda, Yuan Ji, Blase Polite, Chih-Yi Liao
A phase 1 dose-escalation study of RiMO-301 with palliative radiation in advanced tumors
Matthew Koshy, Michael Spiotto, Lawrence Feldman, Jason Luke, Gini Fleming, Daniel Olson, John Moroney, Rita Nanda, Ari Rosenberg, Alexander Pearson, Aditya Juloori, Frank Weinberg, Charles Ray, Ron Gaba, Paul Chang, Linda Janisch, Ze-Qi Xu, Wenbin Lin, Ralph Weichselbaum, Steven Chmura
LUNG-IST-127: A pilot phase II study of maintenance cabozantinib plus pembrolizumab for patients with metastatic squamous non-small cell lung cancer (sqNSCLC) with disease control following induction therapy
Ryan Nguyen, Lucia Notardonato, Alicia Hulbert, Apurva Mallisetty, Frank Weinberg, Israel Rubinstein, Irene Juson, Cindy Chan, Li Liu, Zhengjia Chen, Lawrence Feldman
Risk factors, clinical characteristics, and treatment outcomes for hepatocellular carcinoma in Rwanda
Ange Uwimana, Prince Kubwayo, Damas Dukundane, Menelas Nkeshimana, Ammara Naveed, Neil Gupta, Eric Seruyange, Maarten Bosland, Fidel Rubagumya